In vivo photoacoustics and high frequency ultrasound imaging of mechanical high intensity focused ultrasound (HIFU) ablation by Daoudi, K. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/175051
 
 
 
Please be advised that this information was generated on 2018-07-07 and may be subject to
change.
In vivo photoacoustics and high frequency 
ultrasound imaging of mechanical high 
intensity focused ultrasound (HIFU) ablation 
KHALID DAOUDI,1,* MARTIJN HOOGENBOOM,2 MARTIJN DEN BROK,3 DYLAN 
EIKELENBOOM,3 GOSSE J. ADEMA,3 JÜRGEN J. FÜTTERER,2 AND CHRIS L. 
DE KORTE1 
1Department of Radiology and Nuclear Medicine, Medical UltraSound Imaging Centre, Radboud 
University Nijmegen Medical Centre, Netherlands 
2Department of Radiology and Nuclear Medicine, Radboud University Nijmegen Medical Centre, 
Netherlands 
3Department of Tumor Immunology, Radboud University Nijmegen Medical Centre, Netherlands 
*khalid.daoudi@radboudumc.nl 
Abstract: The thermal effect of high intensity focused ultrasound (HIFU) has been clinically 
exploited over a decade, while the mechanical HIFU is still largely confined to laboratory 
investigations. This is in part due to the lack of adequate imaging techniques to better 
understand the in-vivo pathological and immunological effects caused by the mechanical 
treatment. In this work, we explore the use of high frequency ultrasound (US) and 
photoacoustics (PA) as a potential tool to evaluate the effect of mechanical ablation in-vivo, 
e.g. boiling histotripsy. Two mice bearing a neuroblastoma tumor in the right leg were ablated 
using an MRI-HIFU system conceived for small animals and monitored using MRI 
thermometry. High frequency US and PA imaging were performed before and after the HIFU 
treatment. Afterwards, the tumor was resected for further assessment and evaluation of the 
ablated region using histopathology. High frequency US imaging revealed the presence of 
liquefied regions in the treated area together with fragmentized tissue which appeared with 
different reflecting proprieties compared to the surrounding tissue. Photoacoustic imaging on 
the other hand revealed the presence of deoxygenated blood within the tumor after the 
ablation due to the destruction of blood vessel network while color Doppler imaging 
confirmed the blood vessel network destruction within the tumor. The treated area and the 
presence of red blood cells detected by photoacoustics were further confirmed by the 
histopathology. This feasibility study demonstrates the potential of high frequency US and 
PA approach for assessing in-vivo the effect of mechanical HIFU tumor ablation. 
© 2017 Optical Society of America 
OCIS codes: (170.0110) Imaging systems; (110.5120) Photoacoustic imaging; (170.7170) Ultrasound; (170.1020) 
Ablation of tissue. 
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1. Introduction 
The use of ultrasound (US) in clinical practice is no longer limited to diagnostic imaging and 
needle guidance in tumor biopsy, thanks to the possibility of using high intensity focused 
ultrasound (HIFU) which opened the door for promoting US as a non-invasive therapeutic 
method to treat different diseases [1,2]. US at high intensities is capable of producing both 
thermal and mechanical effects on tissue with non-invasive and selective destruction of a 
targeted tissue volume as a main advantages over other techniques allowing intactness of 
surrounding environment [3]. The thermal effect relies on temperature increase due to the 
absorption of US at the focal spot. This increase can vary depending on the intensity and 
treatment time leading to different stages of tissue destruction ranging from reversible heat 
induced injury (43 to 45 °C) to coagulation necrosis when the temperature exceeds 50 °C [4]. 
Mechanical effects induced by HIFU involves non-thermal tissue destruction and are 
associated with high intensity acoustic pulses, resulting in cavitations, micro-streaming, and 
radiation force leading to disruption of the vascular structure, connective tissue, and cellular 
damage [5, 6]. 
HIFU thermal ablation has been clinically applied for more than a decade to treat a wide 
variety of both benign and malignant tumors including uterine fibroids, prostate cancer, liver 
tumors and other solid tumors that are accessible to US energy [2, 7–9]. On the other hand, 
mechanical HIFU ablation techniques are still in an early stage of development mainly due to 
the poorly understood pathological and immunological effects caused by the treatment in-
vivo. One of the mechanical ablation methods that have been investigated in recent years are 
cavitation cloud histotripsy and boiling histotripsy [10–13]. 
In boiling histotripsy we use millisecond ultrasound pulses with a duty cycle of less than 
2% and acoustic powers which are generally five times as high as which are used for the 
thermal ablations. Using the high power, a shock wave and cavitation effects are taking place 
causing the targeted tissue to be fragmented into submicron sized fragments instead of 
thermal coagulation which occurs during thermal ablations [10–13]. The advantage is that the 
fragmented tissue can easily be absorbed as part of natural physiological healing responses. 
Furthermore, boiling histotripsy provides precise treatment localization. Compared to thermal 
ablation where thermal effect can affect surrounding tissue due to the thermal diffusion, 
mechanical ablation has limited impact on the surrounding since a sharp border between 
destructed and non-destructed tissue is created. Unfortunately, in-vivo reactions of this 
treatment are not well understood and the best way of treatment evaluation and non invasive 
monitoring is still under investigation. Therefore, there is a need for an adequate imaging 
technique to evaluate the effect of boiling histotripsy in-vivo. Additionally, to ensure the 
ablation is performed successfully and with the optimal outcome, the targeted region must be 
monitored non-invasively during and after the treatment. One of the main non-invasive 
methods that have been used to evaluate and monitor the ablation is US and magnetic 
resonance imaging (MRI) [2]. 
Recently photoacoustic imaging (PA) has gained tremendous interest among researchers 
and clinicians [14, 15] and might be an adequate candidate for this application. PA images the 
optical absorption of chromophores deep in highly scattering media. In this method, a short 
pulse of light is used to irradiate the sample of interest. The instantaneous absorption of 
energy by naturally occurring chromophores, or exogenous added dyes, induces a localized 
short temperature rise, which results in the generation of an US pulse via the thermoelastic 
effect. Using US detector placed outside the medium, the generated acoustic waves can be 
detected and by means of image reconstruction, the location of the US sources can be 
determined allowing for a two or three-dimensional visualization of the absorber distribution 
[16, 17]. Using PA as an alternative or add-on method to evaluate thermal HIFU treatment 
has been investigated in several studies [18–23], but to the best of our knowledge, it has never 
been used as a technique to evaluate mechanical ablation such as boiling histotripsy. 
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The purpose of this feasibility study is to investigate the possibility of using PA and high-
frequency US techniques to image in-vivo the effects of boiling histotripsy on tumor 
(neuroblastoma) mouse model. Recently, we set up and applied an MR guided mechanical 
HIFU approach for cancer ablation studies in mice [24–26] where we use extreme HIFU 
pressure to fragmentize the tissue into submicron fragments. In this work we make use of the 
high resolution of high frequency US to assess tissue structure and blood flow using Doppler 
and the high sensitivity of PA to red blood cells to monitor the destruction of blood vessel 
network. Three types of imaging modalities are used in this investigation: MRI to guide the 
HIFU ablation, US and PA to image in-vivo the tumor before ablation and evaluate the treated 
area after the ablation. The tumors, afterward, are resected and processed for histopathology 
to examine the treated area in term of lesion and content. 
2. Materials and methods 
2.1 Animal preparation 
C57Bl/6n wild type mice were purchased from Charles River Wiga (Sulzfeld, Germany) and 
kept under specific pathogen-free conditions in the Central Animal Laboratory of the 
Radboud University (Nijmegen, the Netherlands). All animal experiments were performed 
according to the guidelines and by approval of the Nijmegen Animal Experiments 
Committee. The mice were subcutaneously injected with 0.5 × 10^6 9464D neuroblastoma 
tumor cells at the right femur. 
Isoflurane gas at 3.5% was used for anesthetic induction. The anesthetic concentration 
was adjusted to 1–2% during the experiment in order to maintain the breathing frequency at 
40–60 per minute. The body temperature was measured during the treatment using a rectal 
thermometer and maintained using a heated air flow device. In the PA/US imaging device, a 
heating plate was used to maintain the body temperature. 
2.2 HIFU treatment 
An MR compatible animal HIFU system (Image Guided Therapy—IGT, Pessac, France) was 
used in the experiment, Fig. 1(a). The trajectory of ablation was manually implemented based 
on MR imaging. A 16-channel annular array HIFU transducer, Fig. 1(b) with 3 MHz central 
frequency, 155-160 W acoustic peak power, 86.58° aperture, 48 mm diameter, adjustable 
focus depth 30–80 mm, was embedded in a positioning system (MR compatible piezoelectric 
motors, 30 × 30 mm trajectory execution range, active transducer cooling system) which was 
controlled by trajectory planner software (Thermoguide, IGT, Pessac, France). For good 
acoustic coupling of the US beam, the tumor area was shaved and the remaining hair was 
removed using standard hair removal cream. The mouse was positioned on top of an in-house 
made gel pad in lateral position, with the tumor inside a cavity (approximately 3.5 × 3.5 × 1 
cm) made in the gel pad, and filled with degassed water [24]. 
2.3 Imaging protocol 
The mice were first imaged before the treatment using high frequency US and PA imaging 
using a Vevo LAZR 2100 imaging system Fig. 1(c) equipped with an Nd:YAG laser capable 
of irradiating from 680 to 970 nm (FUJIFILM VisualSonics Inc., Toronto, Canada). 
Subsequently, the ablation took place in a 7T wide bore animal MR scanner where the ablated 
region was monitored using MR thermometry during the treatment. An in-house built surface 
coil was positioned around the tumor. Mice were treated with boiling histotripsy: a pulsed 
wave method utilizing 5ms pulses with an acoustic output power of 160 Watt, pulse repetition 
frequency of 1Hz and 200 pulses per focal spot. A total of 25 spots for mouse 1 and 16 spot 
for mouse 2 (focal size 0.5x0.5x2.0 mm) were focused 1 mm apart in one plane. 
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 Fig. 1. Pictures of the HIFU and imaging system used in the experiment, (a) MR compatible 
animal HIFU system, (b) zoomed image on the 16-channel annular array HIFU transducer used 
for the ablation, (c) Vevo LAZR 2100 system for high frequency US and PA imaging. 
After the treatment T2 weighted and enhanced contrast MR images were made for 
treatment evaluation as described in our previous study [25]. Then the mice went again for 
US and PA imaging. The ultrasound images were obtained using 40 Mhz central frequency 
transducer while PA was performed using 21 Mhz central frequency transducer. In the PA 
experiment, we used 4 wavelengths in the near infrared region (730, 760, 800 and 850 nm). 
Imaging with different modalities was facilitated by PRIME at Radboudumc [27], a center 
which hosts a multitude of imaging modalities. The treated tumors were finally resected and 
processed for histopathology for further analysis. 
3. Results 
3.1 Ultrasound imaging 
Figure 2 shows US images of the tumor of mouse 1 and 2 respectively before Figs. 2(a) and 
2(b) and after Figs. 2(c) and 2(d) the mechanical HIFU treatment where the orange dotted line 
delineates the treated region. In the post-treatment images Figs. 2(c) and 2(d) an echoic region 
with a tissue texture different from the surrounding tissue can be discerned. The region is 
composed of a slightly hyperechoic region (green arrow) caused by fragments of cells and 
collagen debris generated from the boiling histotripsy and a hypoechoic region (red arrow) 
revealing the presence of liquefied region caused by the complete pulverization of the tumor 
cells, and intact cells outside the treated area (yellow arrow). In histopathology, we can 
distinguish the presence of accumulated fragmented tumor cells, chromatin and collagen 
debris in mouse 1, Fig. 2(e) as well as the presence of red blood cells delineated with a blue 
dotted line in the zoomed image. The histopathology image of mouse 2 showed a completely 
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liquefied region with very little red blood cells Fig. 2(f) and collagen more accumulated near 
the border of the lesion. Histopathology shows also sharp borders between treated region 
(green and red arrows) and untreated region (yellow arrow), no viable tumor cells were found 
in the treated region in both mice. 
 
Fig. 2. High-frequency ultrasound images before (a), (b) and after treatment (c), (d) of mouse 1 
and 2 respectively using 40 Mhz ultrasound transducer. (e) and (f) represent the histopathology 
of one slide of the tumors after treatment with 2 zoomed regions each. The green arrow 
indicates the fragments of tumor cells, the red arrow indicates liquefied region, yellow arrow 
indicates non treated tumor region and red blood cells are delineated with a blue dotted line in 
the zoomed region of panel (e). (g) and (h) are MR images of mouse 1 and 2 respectively, left 
image is T2W images and right is contrast enhanced images. 
Since the treatment was performed under MRI guidance, normal T2W and contrast-
enhanced MR Images were obtained. Figures 2(g) and 2(h) shows the MR images of mouse 1 
and mouse 2 respectively. T2w images (left images) reveal the treated region due to the hypo-
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intense border between the treated area and untreated area. Using contrast-enhanced imaging 
(right images) an indication could be made of the leakage of blood vessels due to the presence 
of the contrast in the treated area. 
Furthermore, we investigated blood vessel network distribution within the tumor before 
and after ablation. Figure 3 presents the 3D color Doppler images obtained for both mice. 
Figures 3(a) and 3(b) represent the blood vessel network of mouse 1 and 2 respectively before 
the treatment and Figs. 3(c) and 3(d) are obtained post-treatment. In both mice, color Doppler 
imaging revealed the disappearance of the blood vessel network after the treatment either 
completely, for mouse 1, or partially for mouse 2 where few vessels were still visible at the 
side of the tumor in the untreated part. 
 
Fig. 3. Ultrasound color Doppler of mouse 1 and 2 before treatment (a) and (b) and after 
treatment (c) and (d) respectively 
3.2 Photoacoustic imaging 
Figure 4(a) represents the PA image of mouse 1 before treatment and 4(b) after treatment. 
Pre-treatment PA imaging identifies an absorbing skin layer and absorbing structures at 
different locations within the tumor corresponding to blood vessels. Post-treatment, a large 
absorbing structure with higher signal intensity not visible before the treatment was detected. 
This new and overwhelming signal is most likely caused by the presence of blood 
hemorrhage within the tumor due to the blood vessel destruction. The presence of blood was 
supported by the histopathology as can be seen in the previous Fig. 2(e) (the zoomed region). 
Aggregated red blood cells are present in the treated part of the tumor, delineated with a blue 
dotted line, scattered in between fragmented cell material. The presence of hemorrhage is 
likely caused by rupturing of blood vessels due to the treatment. 
Using photoacoustic spectroscopy (PAS) and least-squares fitting algorithm to unmix the 
images [28] we can reveal the nature of the blood present in the tumor before and after the 
treatment. Figure 4(c) shows the unmixed image before the ablation where we see 
predominantly the presence of oxygenated vessels within the tumor, whereas Fig. 4(d) shows 
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the unmixed image after the ablation which revealed the presence of deoxygenated red blood 
cells inside the treated region. This result corresponds to what one would expect from 
hemorrhage presence following blood vessel disruption. 
On the other hand pre-treatment PAS imaging of mouse 2 revealed the presence of 
oxygenated and deoxygenated blood vessels inside the tumor Fig. 4(e), while, post-treatment 
imaging Fig. 4(f) showed very little deoxygenated blood signal compared to mouse 1. The 
low red blood cell signal detected in the treated area of mouse 2 is likely due to the complete 
pulverization of the cells within the ablated region and the absence of hemorrhage unlike 
mouse 1. Histopathology images Fig. 2(f) showed that a larger liquefied region surrounded by 
intact tissue has resulted from the ablation with a little presence of red blood cells in the 
treated region. 
 
Fig. 4. (a) and (b) pre and post treatment photoacoustic images of mouse 1, (c) and (d) are the 
corresponding unmixed images using melanin, deoxy and oxy hemoglobin spectra, (e) and (f) 
are unmixed images of mouse 2 using the same spectra before and after the ablation 
respectively. 
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4. Discussion and conclusion 
Mechanical HIFU ablation of tumors has the potential to become a major therapeutic means 
in oncology and preclinical investigations are essential to fill the gap in our understanding of 
its pathological and immunological effects in-vivo. Several mechanical effects can be created 
by HIFU ablation depending on the treatment settings. Here, we investigated mechanical 
HIFU using our recently established setting for boiling histotripsy [24, 25]. This relatively 
new technique uses extremely high US pressure to destroy and pulverize the targeted tissue. 
Understanding the impact on pathology and long term recovery as well as the consequences 
for the immune system is a necessity. To tackle this lack of comprehension, we need to study 
in-vivo and non-invasively the effect in different aspects using an adequate real-time imaging 
modality. 
In this feasibility study, we investigated multimodal imaging to detect different effects 
caused by the boiling histotripsy ablation. For the purpose of the study, two mice were 
prepared and injected with neuroblastoma tumor cells in the right leg and both were treated 
with high-pressure amplitudes. We utilized PA imaging with co-registered high frequency US 
to non-invasively image the tumor before and after HIFU ablation. 
Using the PA technique, which is mainly sensitive to blood, we observed the appearance 
of a large absorbing structure in the treated region of mouse 1 while before the treatment we 
saw signals related to the presence of blood vessels inside the tumor Fig. 4. This observation 
was confirmed using histopathology with clear appearance of red blood cells in many parts of 
the treated region. However, point-by-point comparison between histopathology and PA 
images cannot be made here due to the spatial resolution difference between the imaging 
modalities and due to a different PA imaging plane orientation in this experiment with respect 
to the histopathology sections. PAS further allowed extracting the blood characteristics, 
which was classified as deoxygenated post-treatment while the detected vessels were mainly 
oxygenated before the treatment. The deoxygenation can be explained by the presence of red 
blood cells outside the vessels due to their rupture or destruction as a result of the ablation. 
The information about the oxygenation of the ablated region can be crucial in the prediction 
of the outcome after ablation. In fact it has been shown, for example in photodynamic 
therapy, that the remaining oxygenated parts of the tumor after the treatment had more chance 
of tumor recurrence than deoxygenated parts [29]. This demonstrates the importance of 
monitoring oxygenation during and after the treatment which will be performed in future 
study. In the case of mouse 2, red blood cells were less present after the treatment due 
probably to the complete destruction of the blood vessels and pulverization of the cells while 
pre-treatment imaging showed both oxy- and deoxygenated blood vessels within the tumor. 
Histopathology images confirmed the absence of blood cells and a large liquefied region in 
the treated area. 
In this study we used C57bl/6 black mice for proof of principle, which may explain the 
high signal generated by the skin due to the high concentration of the melanin. In future 
studies the use of non-pigmented mice should improve the PA signal generation within the 
tumor. 
The treatment followed a predefined path in MRI-HIFU system and the same pressure 
amplitude and the same number of pulses were applied in each position of the scan for both 
mice. Although both mice were successfully treated and no intact tumor cells were seen 
inside the ablated area, the high resolution of high frequency US imaging revealed different 
structures in both mice. The high frequency US images of the mouse 2 have shown the treated 
area composed of large hypoechoic region revealing the liquid nature of the ablated region. 
The histopathology study confirmed the US findings and revealed the ablated region to be 
composed of a completely liquefied region containing emulsified tumor debris and probably 
edema. Images of mouse 1 revealed a region with mainly hyperechoic structure caused by 
regions with accumulation of larger fragments of pulverized cells and red blood cells which 
leaked out from ruptured vessels. MRI, on the other hand, allowed detecting the treated area 
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using T2w and contrast enhanced imaging. However compared to ultrasound, MR images 
looked similar in both mice which shows its limitations to distinguish the nature of the 
ablation and whether the treated cells were completely fragmented or not. Furthermore, the 
MR images were not suitable to determine the amount of fragmentation as well as to 
differentiate between edema effects or major hemorrhage which was possible with PA due to 
its sensitivity to red blood cells allowing the detection of hemorrhage within the treated area 
and revealing its oxygenation status. A study including a larger number of mice will be 
needed to address to what extend high frequency US imaging and PA can be used to more 
precisely monitor ablation efficacy by mechanical HIFU treatment beyond the sensitivity of 
MRI and to thoroughly investigate the differences in fragmentation and hemorrhage between 
mice. 
The treatment destroyed the blood vessels within the tumor as evidenced by color Doppler 
images Fig. 3. The figures have shown clear differences in blood vessel network before and 
after treatment in both tumors. Most of the detected vessels before the treatment were not any 
longer visible after the ablation. In this study, the mice were treated in an MRI-HIFU system 
and imaged using Vevo 2100 system. We are aware that moving the mouse in between 
imaging set-ups may affect the result, especially US Doppler imaging where the orientation is 
crucial. However, since we acquired 3D US, color Doppler and PA data of the whole tumor, 
co-registration of the treatment region as assessed with MRI and the US-based data was 
facilitated. Consequently, we were able to reproduce the same configuration before and after 
the treatment. Future work will focus on performing the HIFU ablation within the Vevo 
system in order to monitor the mice during the treatment. In fact PA and US can also be used 
as a method to monitor temperature increase during thermal treatment [23, 30, 31]. This will 
allow avoiding any interpretational errors which may be caused by using a different HIFU 
guided system. 
This feasibility study proves that the combination of PA and high frequency US imaging 
can be a powerful tool to better understand the effect of boiling histotripsy. While US gives 
an indication of the anatomy and the nature of the lesion and color Doppler reveals the 
vasculature, PA will provide more insights in the presence of blood in vessels or in the 
liquefied region and the oxygenation state of the blood in the tumor using spectroscopy. The 
results presented here will act as a baseline for a larger follow-up study to improve the HIFU 
treatment, to monitor tumor response over time such as regrowth of blood vessels and the 
long term ablation outcome and to investigate the physiological effects of the treatment. 
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